As expected, the HCC group showed a significant increased Alfa fetoprotein (AFP) level compared to CLD patients (p = 0.02), as well as prothrombin time expressed as an international normalized ratio (INR) (p = 0.005) and decreased level of hemoglobin (p = 0.011). This evidence concerns the gene F2 and hepatocellular carcinoma.